Research Institute of Molecular Pathology (IMP)

The Research Institute of Molecular Pathology (IMP) in Vienna is a basic biomedical research institute largely sponsored by Boehringer Ingelheim. With over 200 scientists from 40 countries, the IMP is committed to scientific discovery of fundamental molecular and cellular mechanisms underlying complex biological phenomena. Research areas include cell and molecular biology, microscopy, immunology and cancer, developmental biology, chromosome biology, and computational biology

Molecular biology,disease mechanisms,computational biology,immunology,cell biology,chromosome biology,gene regulation,developmental biology,and microscopy

Research institute of molecular pathology (imp) operates in the Research industry.

Research institute of molecular pathology (imp)'s revenue is 11m - 100m

Research institute of molecular pathology (imp) has 51 - 200 employees.